LIC Healthcare Fund - Direct Plan - Growth
Equity
Direct
Sector - Healthcare
NAV: ₹ 20.1 as on 22-09-2023
Fund Performance
22 people have invested ₹ 2L in LIC Healthcare Fund - Direct Plan - Growth in the last three months
Fund Insights
In the last 3 years, SBI Healthcare Opportunities Fund Direct Growth has given 17.67% return, outperforming this fund by 9.51% per annum.
In the last 1 year, SBI Healthcare Opportunities Fund Direct Growth has given 28.34% return, outperforming this fund by 16.16%.
Over the last 1 month, this fund has experienced a 5.0% drop in AUM moving from 54.44 Cr to 51.74 Cr.
This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 1.21% which is lower than the category average expense ratio of 1.53%.
INDmoney Rank
Powered by IND quant engine
IND ranking is not available for this fund.
Pros
3Y returns in the top 25% of the category
Cons
No bad points found for this fund.
About the Fund
LIC Healthcare Fund - Direct Plan - Growth is an equity fund. This fund was started on 28 February, 2019. The fund is managed by Karan Doshi. The fund could potentially beat inflation in the long-run.
Key Parameters
- LIC Healthcare Fund - Direct Plan - Growth has ₹52 Cr worth of assets under management (AUM) as on Aug 2023 and is less than category average.
- The fund has an expense ratio 1.2.
LIC Healthcare Fund - Direct Plan - Growth Overview
 | 1.21% |
 Benchmark | S&P BSE Healthcare PR |
 | ₹52 Cr |
 | 28 February, 2019 |
 | ₹5000/₹500 |
 Exit Load | 1% |
 | No Lock-in |
 TurnOver | 414.8% |
Fund Distribution as on (31-Aug-23)
Size breakup
Large cap
52.8%
Mid cap
26.5%
Small cap
15.6%
Sector Allocation
Health
100%
Top Holdings of LIC Healthcare Fund - Direct Plan - Growth as on (31-Aug-23)
Equity Holdings16
Holdings | Weight% | 1M Change | |
|---|---|---|---|
 Sun Pharmaceuticals Industries Ltd | 15.28% | -11% | |
 Dr Reddy's Laboratories Ltd | 9.75% | 0% | |
 Apollo Hospitals Enterprise Ltd | 8.77% | 0% | |
 Divi's Laboratories Ltd | 7.81% | -14.1% | |
 J.B. Chemicals & Pharmaceuticals Ltd Shs Dematerialised | 7.76% | 0% |
See all
LIC Healthcare Fund - Direct Plan - Growth: Monthly Changes Updates
All changes are between Jun'23 and Aug'23
Fund Performance
- This fund’s returns stands at -0.74% whereas the fund’s underlying benchmark Nifty 500 returns stands at -0.74% as on Aug'23
- This fund outperformed Nifty 500 by 0.00% in Aug'23
AUM Change
- AUM of the fund stands at 51.7 Cr as of Aug'23
- AUM decreased by 2.7 Cr between Aug'23 and Jul'23
Fund Portfolio Changes
Gainers & Losers in LIC Healthcare Fund - Direct Plan - Growth portfolio Returns for the month of Aug
Top Growth Drivers | 1M Return |
|---|---|
 Laurus Labs Ltd | 11.5% |
 J B Chemicals & Pharmaceuticals Ltd | 7.5% |
 Cipla Ltd | 6.7% |
Peer Analysis
LIC Healthcare Fund - Direct Plan - Growth Fund Manager
Karan Doshi
Fund Manager of LIC Healthcare Fund - Direct Plan - Growth, since 31 July 2023
Top funds managed
Fund Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 16.49% since inception which is less than its category average return of 16.55%
Fund Allocations
This fund has an allocation of 94.89% in Equity, 0% in Debt and 5.11% in Cash related instruments
AUM size ₹52 Cr
This fund has AUM of ₹52 Cr which is less than its category average of ₹ 1366 Cr
Expense Ratio 1.21%
This fund has an expense ratio of 1.21% which is less than its category average expense ratio of 1.49%
Frequently Asked Questions
The current NAV of LIC Healthcare Fund - Direct Plan - Growth is ₹20.07 as on 22-Sep-2023.
Existing (Absolute + CAGR) as on 22-Sep-2023.
LIC Healthcare Fund - Direct Plan - Growth | Absolute Returns | CAGR Returns |
1 Month Returns | -1.77% | -1.77% |
6 Month Returns | 21.34% | 21.34% |
1 Year Returns | 12.18% | 12.18% |
3 Years Returns | 26.54% | 8.16% |
5 Years Returns | 0% | 0% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
1.21% as on August 2023
₹52 Cr as on August 2023
Sun Pharmaceuticals Industries Ltd(15.28%), Dr Reddy's Laboratories Ltd(9.75%), Apollo Hospitals Enterprise Ltd(8.77%), Divi's Laboratories Ltd(7.81%), J.B. Chemicals & Pharmaceuticals Ltd Shs Dematerialised(7.76%) as on August 2023
The alpha ratio for the LIC Healthcare Fund - Direct Plan - Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
LIC Healthcare Fund - Direct Plan - Growth | -7.26 | -3.89 | - |
As on August 2023
The alpha for LIC Healthcare Fund - Direct Plan - Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the LIC Healthcare Fund - Direct Plan - Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
LIC Healthcare Fund - Direct Plan - Growth | 0.91 | 0.91 | - |
As on August 2023
The Beta for LIC Healthcare Fund - Direct Plan - Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the LIC Healthcare Fund - Direct Plan - Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
LIC Healthcare Fund - Direct Plan - Growth | 0.46 | 0.43 | - |
As on August 2023
The sharpe ratio for LIC Healthcare Fund - Direct Plan - Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the LIC Healthcare Fund - Direct Plan - Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
LIC Healthcare Fund - Direct Plan - Growth | 13.15 | 14.44 | - |
As on August 2023
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 0.69 as on August 2023. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Karan Doshi is the fund manager of LIC Healthcare Fund - Direct Plan - Growth
The Exit load of LIC Healthcare Fund - Direct Plan - Growth is 1%